These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20436664)

  • 1. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.
    Coppo P; Schwarzinger M; Buffet M; Wynckel A; Clabault K; Presne C; Poullin P; Malot S; Vanhille P; Azoulay E; Galicier L; Lemiale V; Mira JP; Ridel C; Rondeau E; Pourrat J; Girault S; Bordessoule D; Saheb S; Ramakers M; Hamidou M; Vernant JP; Guidet B; Wolf M; Veyradier A;
    PLoS One; 2010 Apr; 5(4):e10208. PubMed ID: 20436664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.
    Coppo P; Bengoufa D; Veyradier A; Wolf M; Bussel A; Millot GA; Malot S; Heshmati F; Mira JP; Boulanger E; Galicier L; Durey-Dragon MA; Frémeaux-Bacchi V; Ramakers M; Pruna A; Bordessoule D; Gouilleux V; Scrobohaci ML; Vernant JP; Moreau D; Azoulay E; Schlemmer B; Guillevin L; Lassoued K;
    Medicine (Baltimore); 2004 Jul; 83(4):233-244. PubMed ID: 15232311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity.
    Malak S; Wolf M; Millot GA; Mariotte E; Veyradier A; Meynard JL; Korach JM; Malot S; Bussel A; Azoulay E; Boulanger E; Galicier L; Devaux E; Eschwège V; Gallien S; Adrie C; Schlemmer B; Rondeau E; Coppo P;
    Scand J Immunol; 2008 Sep; 68(3):337-44. PubMed ID: 18782260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.
    Fujimura Y; Matsumoto M
    Intern Med; 2010; 49(1):7-15. PubMed ID: 20045995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.
    Benhamou Y; Boelle PY; Baudin B; Ederhy S; Gras J; Galicier L; Azoulay E; Provôt F; Maury E; Pène F; Mira JP; Wynckel A; Presne C; Poullin P; Halimi JM; Delmas Y; Kanouni T; Seguin A; Mousson C; Servais A; Bordessoule D; Perez P; Hamidou M; Cohen A; Veyradier A; Coppo P;
    J Thromb Haemost; 2015 Feb; 13(2):293-302. PubMed ID: 25403270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy.
    Samia NI; Friedman KD; Gottschall JL; Raife TJ
    J Clin Apher; 2011; 26(3):138-45. PubMed ID: 21462238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.
    Cataland SR; Yang S; Wu HM
    Br J Haematol; 2012 May; 157(4):501-3. PubMed ID: 22296585
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Benhamou Y; Assié C; Boelle PY; Buffet M; Grillberger R; Malot S; Wynckel A; Presne C; Choukroun G; Poullin P; Provôt F; Gruson D; Hamidou M; Bordessoule D; Pourrat J; Mira JP; Le Guern V; Pouteil-Noble C; Daubin C; Vanhille P; Rondeau E; Palcoux JB; Mousson C; Vigneau C; Bonmarchand G; Guidet B; Galicier L; Azoulay E; Rottensteiner H; Veyradier A; Coppo P;
    Haematologica; 2012 Aug; 97(8):1181-6. PubMed ID: 22580997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.
    Matsuyama T; Kuwana M; Matsumoto M; Isonishi A; Inokuma S; Fujimura Y
    Thromb Haemost; 2009 Aug; 102(2):371-8. PubMed ID: 19652889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer awareness in atypical thrombotic microangiopathies.
    Oberic L; Buffet M; Schwarzinger M; Veyradier A; Clabault K; Malot S; Schleinitz N; Valla D; Galicier L; Bengrine-Lefèvre L; Gorin NC; Coppo P;
    Oncologist; 2009 Aug; 14(8):769-79. PubMed ID: 19684072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
    Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
    Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies.
    Nieto JM; De La Fuente-Gonzalo F; González FA; Villegas A; Martínez R; Fuentes ME; Ropero P
    Clin Chem Lab Med; 2018 Jan; 56(2):294-302. PubMed ID: 28796639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
    Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
    Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
    Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
    Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.
    Ferrari S; Scheiflinger F; Rieger M; Mudde G; Wolf M; Coppo P; Girma JP; Azoulay E; Brun-Buisson C; Fakhouri F; Mira JP; Oksenhendler E; Poullin P; Rondeau E; Schleinitz N; Schlemmer B; Teboul JL; Vanhille P; Vernant JP; Meyer D; Veyradier A;
    Blood; 2007 Apr; 109(7):2815-22. PubMed ID: 17164349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
    Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
    Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.